Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Disease
Abstract Neuro-inflammatory processes that contribute to development of Alzheimer’s are evident early in the latent prodromal phase and worsen during the course of the disease. Despite substantial mechanistic and clinical evidence of inflammation, therapeutic approaches targeting inflammation have failed to alter the course of the disease. Disparate results from epidemiological and clinical trial
Abstract Neuro-inflammatory processes that contribute to development of Alzheimer’s are evident early in the latent prodromal phase and worsen during the course of the disease. Despite substantial mechanistic and clinical evidence of inflammation, therapeutic approaches targeting inflammation have failed to alter the course of the disease. Disparate results from epidemiological and clinical trials targeting inflammation, highlight the complexity of the inflammatory process. Herein we review the dynamics of the inflammatory process across aging, midlife endocrine transitions, and the APOEε4…
related reading
- Frontiers | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer’s Diseasefrontiersin.org
- The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
- APOE2 is associated with longevity independent of Alzheimer’s diseasencbi.nlm.nih.gov
- Bottlenecks of Aging - Amaranth Foundationamaranth.foundation
- Nintil - The Longevity FAQnintil.com
- APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease | Nature Medicinenature.com
- Longevity FAQ - Laura Demingldeming.com
- Drug Discovery for Menopause with Gero and AthenaBIOathenadao.substack.com
- Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
- Alzheimer’s drug trial explores gut-brain linknature.com
- What we wish we knew entering the aging fieldlibrariesforthefuture.bio
- Your Review: Of Mice, Mechanisms, and Dementiaastralcodexten.com